Association between CD20
CD20+ T lymphocytes
compartmentalized inflammation
fatigue
multiple sclerosis
neuropsychological
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
revised:
17
09
2024
received:
23
07
2024
accepted:
15
10
2024
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
aheadofprint
Résumé
CD20 We enrolled 90 MS patients. Each patient underwent cognitive assessment (Brief International Cognitive Assessment for Multiple Sclerosis) and psychometric assessment (modified Fatigue Impact Scale, Beck Anxiety Inventory, Beck Depression Inventory, Pittsburgh Sleep Quality Index). Cognitive status was defined through the cerebral functional score. Forty-four of 90 patients were relapsing-remitting (49%) and 46 were progressive patients (51%). Seventy patients (18.9%) showed CD20 The presence of CD20
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
CD20
METHODS
METHODS
We enrolled 90 MS patients. Each patient underwent cognitive assessment (Brief International Cognitive Assessment for Multiple Sclerosis) and psychometric assessment (modified Fatigue Impact Scale, Beck Anxiety Inventory, Beck Depression Inventory, Pittsburgh Sleep Quality Index). Cognitive status was defined through the cerebral functional score.
RESULTS
RESULTS
Forty-four of 90 patients were relapsing-remitting (49%) and 46 were progressive patients (51%). Seventy patients (18.9%) showed CD20
CONCLUSIONS
CONCLUSIONS
The presence of CD20
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16536Informations de copyright
© 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Filippi M, Bar‐Or A, Piehl F, et al. Multiple Sclerosis. Nat Rev Dis Primers. 2018;4(1):43. doi:10.1038/s41572-018-0041-4
Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378(2):169‐180. doi:10.1056/nejmra1401483
Bar‐Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol. 2021;20(6):470‐483. doi:10.1016/S1474-4422(21)00063-6
Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8(3):1‐15. doi:10.1101/cshperspect.a028936
Von Essen MR, Ammitzbøll C, Hansen RH, et al. Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis. Brain. 2019;142(1):120‐132. doi:10.1093/brain/awy301
Holley JE, Bremer E, Kendall AC, et al. CD20+inflammatory T‐cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination. Mult Scler Relat Disord. 2014;3(5):650‐658. doi:10.1016/j.msard.2014.06.001
Yigit P, Acikgoz A, Mehdiyev Z, Dayi A, Ozakbas S. The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir J Med Sci. 2021;190(3):1129‐1136. doi:10.1007/s11845-020-02377-2/Published
Manjaly ZM, Harrison NA, Critchley HD, et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(6):642‐651. doi:10.1136/jnnp-2018-320050
Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing‐remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144‐1150. http://www.r‐project.org
Carotenuto A, Valsasina P, Preziosa P, Mistri D, Filippi M, Rocca MA. Monoaminergic network abnormalities: a marker for multiple sclerosis‐related fatigue and depression. J Neurol Neurosurg Psychiatry. 2022;94(2):94‐101. doi:10.1136/jnnp-2022-330109
Margoni M, Valsasina P, Bacchetti A, et al. Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis. Mol Psychiatry. 2024;29:2647‐2656. doi:10.1038/s41380-024-02532-6
Touil H, Li R, Zuroff L, et al. Cross‐talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine. 2023;96:104789 www.thelancet.com
Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162‐173. doi:10.1016/S1474-4422(17)30470-2
Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis ‐the 2013 revisions. Neurology. 2014;83(3):278‐286.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444‐1452. doi:10.1212/wnl.33.11.1444
Goretti B, Niccolai C, Hakiki B, et al. The brief international cognitive assessment for multiple sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. BMC Neurol. 2014;14:1‐6. http://www.biomedcentral.com/1471‐2377/14/171
Sacco R, Santangelo G, Stamenova S, et al. Psychometric properties and validity of Beck depression inventory II in multiple sclerosis. Eur J Neurol. 2016;23(4):744‐750. doi:10.1111/ene.12932
Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the modified fatigue impact scale in four different European countries. Mult Scler J. 2005;11(1):76‐80. doi:10.1191/1352458505ms1117oa
Ghisi M, Sica C. The Italian Versions of the Beck Anxiety Inventory and the Beck Depression Inventory‐Ii: Psychometric Properties and Discriminant Power; 2007. In M. A. Lange (Ed.), Leading‐edge psychological tests and testing research (pp.27‐50.). Nova Science Publishers.
Scialpi A, Mignolli E, De Vito C, et al. Italian validation of the Pittsburgh sleep quality index (PSQI) in a population of healthy children: a cross sectional study. Int J Environ Res Public Health. 2022;19(15):1‐8. doi:10.3390/ijerph19159132
Eggleton P, Bremer E, Tarr JM, et al. Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects. Arthritis Res Ther. 2011;13:1‐15. http://arthritis‐research.com/content/13/6/R208
Lee AYS. CD20+ T cells: an emerging T cell subset in human pathology. Inflamm Res. 2022;71(10–11):1181‐1189. doi:10.1007/s00011-022-01622-x
von Essen MR, Talbot J, Hansen RHH, et al. Intrathecal CD8 + CD20 + T cells in primary progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2023;10(5):1‐9. doi:10.1212/NXI.0000000000200140
Derache N, Grassiot B, Mézenge F, et al. Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in relapsing‐remitting‐multiple sclerosis patients at the earlier stage of the disease: a PET/MR study. Mult Scler Relat Disord. 2013;2(4):362‐369. doi:10.1016/j.msard.2013.03.005
Tedeschi G, Dinacci D, Lavorgna L, et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J Neurol Sci. 2007;263(1–2):15‐19. doi:10.1016/j.jns.2007.07.004
Airas L, Rissanen E, Rinne JO. Imaging neuroinflammation in multiple sclerosis using TSPO‐PET. Clin Translat Imaging. 2015;3(6):461‐473. doi:10.1007/s40336-015-0147-6
Patrick E, Christodoulou C, Krupp LB. Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler. 2009;15:258‐261. doi:10.1177/1352458508097466
Kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler. 2000;6:131‐136. doi:10.1177/135245850000600213